{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:42:23Z","timestamp":1740156143739,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12664-023-01515-9","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T07:02:11Z","timestamp":1708930931000},"page":"1203-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal dysfunction in routine proton-pump inhibitor use may be linked to comorbidities: A real-world observational study"],"prefix":"10.1007","volume":"43","author":[{"given":"Adeshkumar","family":"Andhale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-3306","authenticated-orcid":false,"given":"Philip","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Dhoble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Bhangale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"1515_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5056\/jnm18001","volume":"24","author":"Y Kinoshita","year":"2018","unstructured":"Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018;24:182\u201396.","journal-title":"J Neurogastroenterol Motil"},{"key":"1515_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238\u201346.","journal-title":"JAMA Intern Med"},{"key":"1515_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-016-0325-4","volume":"17","author":"P Arora","year":"2016","unstructured":"Arora P, Gupta A, Golzy M, et al. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease. BMC Nephrol. 2016;17:1\u20138.","journal-title":"BMC Nephrol"},{"key":"1515_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/j.gastro.2017.05.046","volume":"153","author":"DCF Klatte","year":"2017","unstructured":"Klatte DCF, Gasparini A, Xu H, et al. Association between proton pump inhibitor use and risk. Gastroenterology. 2017;153:702\u201310.","journal-title":"Gastroenterology"},{"key":"1515_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019;157:682\u201391.","journal-title":"Gastroenterology"},{"key":"1515_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12664-023-01428-7","volume":"42","author":"AK Dutta","year":"2023","unstructured":"Dutta AK, Jain A, Jearth V, et al. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian J Gastroenterol. 2023;42:601\u201328.","journal-title":"Indian J Gastroenterol"},{"key":"1515_CR7","first-page":"336","volume":"12","author":"KG Blass","year":"1974","unstructured":"Blass KG, Thibert RJ, Lam LK. A study of the mechanism of the Jaff\u00e9 reaction. Z Klin Chem Klin Biochem. 1974;12:336\u201343.","journal-title":"Z Klin Chem Klin Biochem"},{"key":"1515_CR8","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1093\/ndt\/gfr003","volume":"26","author":"JAJG Van den Brand","year":"2011","unstructured":"Van den Brand JAJG, van Boekel GAJ, Willems HL, Kiemeney LALM, den Heijer M, Wetzels JFM. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dialysis Transplant. 2011;26:3176\u201381.","journal-title":"Nephrol Dialysis Transplant"},{"key":"1515_CR9","doi-asserted-by":"crossref","unstructured":"Chapter 1: Definition and classification of CKD. Kidney Int. Suppl (2011). 2013;3:19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"1515_CR10","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO). Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl. 2012;2:1138."},{"key":"1515_CR11","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","volume":"91","author":"Y Xie","year":"2017","unstructured":"Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int. 2017;91:1482\u201394.","journal-title":"Kidney Int"},{"key":"1515_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/pds.3329","volume":"21","author":"CE Leonard","year":"2012","unstructured":"Leonard CE, Freeman CP, Newcomb CW, et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf. 2012;21:1155\u201372.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1515_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diabres.2018.11.019","volume":"147","author":"H Yang","year":"2019","unstructured":"Yang H, Juang SY, Liao KF. Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients. Diabetes Res Clin Pract. 2019;147:67\u201375.","journal-title":"Diabetes Res Clin Pract"},{"key":"1515_CR14","first-page":"6465","volume":"11","author":"B Wu","year":"2018","unstructured":"Wu B, Shang W, Li Y, et al. Association between proton pump inhibitors use and kidney diseases: a meta-analysis. Int J Clin Exp Med. 2018;11:6465\u201373.","journal-title":"Int J Clin Exp Med"},{"key":"1515_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cegh.2017.12.008","volume":"7","author":"S Hussain","year":"2019","unstructured":"Hussain S, Singh A, Habib A, Najmi AK. Proton pump inhibitors use and risk of chronic kidney disease: evidence-based meta-analysis of observational studies. Clin Epidemiol Global Health. 2019;7:46\u201352.","journal-title":"Clin Epidemiol Global Health"},{"key":"1515_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0204231","volume":"13","author":"A Rodr\u00edguez-Poncelas","year":"2018","unstructured":"Rodr\u00edguez-Poncelas A, Barcel\u00f3 MA, Saez M, Coll-de-Tuero G. Duration and dosing of proton pump inhibitors associated with high incidence of chronic kidney disease in population-based cohort. PLoS ONE. 2018;13:1\u201316.","journal-title":"PLoS ONE"},{"key":"1515_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/phar.2235","volume":"39","author":"E Hart","year":"2019","unstructured":"Hart E, Dunn TE, Feuerstein S, Jacobs DM. Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study. Pharmacotherapy. 2019;39:443\u201353.","journal-title":"Pharmacotherapy"},{"key":"1515_CR18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1053\/j.gastro.2019.10.023","volume":"158","author":"C Ma","year":"2020","unstructured":"Ma C, Shaheen AA, Congly SE, Andrews CN, Moayyedi P, Forbes N. Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-year analysis of national ambulatory data. Gastroenterology. 2020;158:780\u20132.","journal-title":"Gastroenterology"},{"key":"1515_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nrgastro.2011.272","volume":"9","author":"P Moayyedi","year":"2012","unstructured":"Moayyedi P, Leontiadis GI. The risks of PPI therapy. Nat Rev Gastroenterol Hepatol. 2012;9:132\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1515_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/AOG.0b013e31826af61a","volume":"120","author":"DA Grimes","year":"2012","unstructured":"Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol. 2012;120:920\u20137.","journal-title":"Obstet Gynecol"},{"key":"1515_CR21","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1681\/ASN.2015121377","volume":"27","author":"Y Xie","year":"2016","unstructured":"Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2016;27:3153\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"1515_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/kisup.2013.79","volume":"3","author":"R Kazancio\u01e7lu","year":"2013","unstructured":"Kazancio\u01e7lu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3:368\u201371.","journal-title":"Kidney Int Suppl"},{"key":"1515_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/gastro\/gox009","volume":"5","author":"T Bucsics","year":"2017","unstructured":"Bucsics T, Krones E. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep. 2017;5:127\u201337.","journal-title":"Gastroenterol Rep"},{"key":"1515_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1741-7015-11-95","volume":"11","author":"A Kronbichler","year":"2013","unstructured":"Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med. 2013;11:95.","journal-title":"BMC Med"},{"key":"1515_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3109\/0886022X.2014.917560","volume":"36","author":"X Wu","year":"2014","unstructured":"Wu X, Zhang W, Ren H, Chen X, Xie J, Chen N. Diuretics-associated acute kidney injury: clinical and pathological analysis. Ren Fail. 2014;36:1051\u20135.","journal-title":"Ren Fail"},{"key":"1515_CR26","first-page":"457","volume":"7","author":"GS Pazhayattil","year":"2014","unstructured":"Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis. 2014;7:457\u201368.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"1515_CR27","doi-asserted-by":"publisher","first-page":"c89","DOI":"10.1159\/000326682","volume":"119","author":"KA Oikonomou","year":"2011","unstructured":"Oikonomou KA, Kapsoritakis AN, Stefanidis I, Potamianos SP. Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron Clin Pract. 2011;119:c89\u201396.","journal-title":"Nephron Clin Pract"},{"key":"1515_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5527\/wjn.v4.i2.271","volume":"4","author":"NM Mehmet","year":"2015","unstructured":"Mehmet NM. Effect of urinary stone disease and its treatment on renal function. World J Nephrol. 2015;4:271.","journal-title":"World J Nephrol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-023-01515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-023-01515-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-023-01515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T16:02:53Z","timestamp":1730649773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-023-01515-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1515"],"URL":"https:\/\/doi.org\/10.1007\/s12664-023-01515-9","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"type":"print","value":"0254-8860"},{"type":"electronic","value":"0975-0711"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AA, PA, PD, DD, AJ, TG, JK and NB\u00a0declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The protocol of the study and related documents were approved by the institutional review board (Project No. 1207\u201318-PA). Written informed consent was obtained from all participating subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to the publication of the manuscript in the Indian Journal of Gastroenterology.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}